Director Darren Black Sells Over $30 Million in LifeStance Health Shares
summarizeSummary
Director Darren M. Black, through affiliated funds, sold 4.3 million shares of LifeStance Health Group, Inc. common stock for a total value of $30.2 million.
check_boxKey Events
-
Director Executes Major Share Sale
Darren M. Black, a Director of LifeStance Health Group, Inc., reported an open market sale of 4,314,939 shares of common stock on March 2, 2026, at a price of $7.01 per share, totaling $30,247,722.
-
Sale Linked to Institutional Dispositions
This transaction occurred on the same day as the closing of a secondary offering where selling stockholders disposed of 25 million shares, indicating a broader trend of institutional selling. The 10-K filed on February 25, 2026, had previously disclosed a director's plan to sell 1.5 million shares, making this larger execution a notable development.
auto_awesomeAnalysis
Director Darren M. Black, through affiliated investment funds, executed a substantial open market sale of LifeStance Health Group shares totaling over $30 million. This significant disposition, representing more than 1% of the company's market capitalization, follows closely on the heels of a recently closed secondary offering where institutional investors sold 25 million shares. While the 10-K filed on February 25, 2026, mentioned a director's plan to sell 1.5 million shares, this Form 4 reports a larger sale of 4.3 million shares by Director Black's affiliated entities. Such a large sale by a director, even if indirect, can be perceived negatively by the market, suggesting a lack of conviction or a move to lock in gains following the company's recent return to profitability.
At the time of this filing, LFST was trading at $7.33 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $3.74 to $8.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.